Page last updated: 2024-08-25

rosiglitazone and efatutazone

rosiglitazone has been researched along with efatutazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araki, K; Fujii, K; Fujimoto, K; Kuroha, M; Matsui, Y; Mori, M; Ogata, T; Ohsumi, J; Onishi, Y; Sawamura, R; Shimada, K; Shinozuka, T; Tanaka, J; Tani, Y; Tokumaru, E; Tsukada, T; Wakimoto, S; Watanabe, N; Yamamoto, H	1

Other Studies

1 other study(ies) available for rosiglitazone and efatutazone

Article	Year
Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification. Bioorganic & medicinal chemistry, 2018, 10-01, Volume: 26, Issue:18 Topics: Administration, Oral; Animals; Chlorocebus aethiops; COS Cells; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Hypoglycemic Agents; Macaca fascicularis; Male; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Structure; PPAR gamma; Rats; Rats, Wistar; Rats, Zucker; Structure-Activity Relationship	2018

Article

Year

Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification.

Bioorganic & medicinal chemistry, 2018, 10-01, Volume: 26, Issue:18

Topics: Administration, Oral; Animals; Chlorocebus aethiops; COS Cells; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Hypoglycemic Agents; Macaca fascicularis; Male; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Structure; PPAR gamma; Rats; Rats, Wistar; Rats, Zucker; Structure-Activity Relationship

2018